Metabolic Side Effects of Drugs and Substances

Preferred Label : Metabolic Side Effects of Drugs and Substances;

MeSH definition : Specific effects of drugs and substances on metabolic pathways such as those occurring through the CYTOCHROME P-450 ENZYME SYSTEM. These include effects that often result in DRUG INTERACTIONS; FOOD-DRUG INTERACTIONS; and HERB-DRUG INTERACTIONS.;

MeSH hyponym : Metabolic Side Effects of Drugs; Metabolic Side Effects of Substances; Substance Effects on Metabolism; Drug Effects on Metabolism;

MeSH annotation : used for searching; INDEXER: Do not use; CATALOGER: Do not use;

Is substance : O;

Détails

Origin ID

D065606;

UMLS CUI

C3850157;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Record concept(s)
- Metabolic Side Effects of Drugs [MeSH concept]
- Metabolic Side Effects of Drugs and Substances [MeSH concept]
- Metabolic Side Effects of Substances [MeSH concept]
See also
- drug interactions [MeSH Descriptor]
- food-drug interactions [MeSH Descriptor]
- herb-drug interactions [MeSH Descriptor]
See also inter- (CISMeF)
- cytochrome P-450 enzyme substrate [SYNODOS term]
Semantic type(s)
- Pathologic Function [UMLS semantic type]
Substance(s)
- 3-phenoxybenzoic acid [MeSH Supplementary Concept]
- Modafinil [MeSH Descriptor]
- Oxcarbazepine [MeSH Descriptor]
- avasimibe [MeSH Supplementary Concept]
- carbamazepine [MeSH Descriptor]
- montelukast [MeSH Supplementary Concept]
- nevirapine [MeSH Descriptor]
- phenobarbital [MeSH Descriptor]
- phenytoin [MeSH Descriptor]
- rifampin [MeSH Descriptor]

Position du mot-clé dans l'(les) arborescence(s) :

Consulter ci-dessous une sélection des principales ressources :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients